RALEIGH, N.C., October 5, 2011 – Compliance Implementation Services (CIS), a leading life sciences consulting firm, announced today that Mertie V. Snead has been named Vice President, Clinical Compliance in which she will oversee the Global Clinical R&D Practice Group and join CIS’ management team.
“With nearly 20 years of industry experience, Mertie brings the vast knowledge and clinical project management needed to not only lead CIS’ clinical compliance team, but also to provide strategic business direction for building lasting client relationships,” said Toni Barsh, VP Account Management and CIS Co-founder. “She brings the insight needed to navigate complex regulatory challenges and develop a comprehensive compliance management plan and ensure its implementation. Mertie will focus client solutions on their needs, size and resources for successful clinical research and development compliance.”
In her role, Ms. Snead will lead the strategy and growth of CIS’ clinical business area to effectively help clients evaluate inspection-readiness and understand GCP regulatory requirements. Her past experience includes establishing an internal Clinical Quality Management function within a major Europe-based vaccines company, directing global clinical quality assurance teams, leading the strategic direction for quality assurance operations (audit management, CAPA management, inspection management). Ms. Snead has extensive experience in the management and follow-up for FDA and international regulatory inspections. Throughout her career Ms. Snead has succeeded in building quality partnerships with CRO’s, contract quality assurance providers, IRBs, strategic alliance partners and regulatory agencies.
Ms. Snead comes to CIS after 19 years at a major pharmaceutical company and a total of 25 years industry experience. She most recently held the position of Director/Head of Global Quality & Compliance Externalization. In this role, Ms. Snead partnered with Business Development, Legal and R&D Medicines Development to establish a quality and compliance governance framework for strategic alliances and co-development partnerships. She has also held Research and Development positions in the areas of pre-clinical toxicology, GLP quality assurance, clinical data management, corporate compliance investigations, clinical monitoring /study management and GCP quality assurance. Ms. Snead holds membership in the North Carolina Chapter Society of Quality Assurance and the Healthcare Business Women Association, Research Triangle Park Chapter.
About CIS
Compliance Implementation Services (CIS) is a life sciences consulting firm specializing in compliance strategies for pharmaceutical, biotech, and medical device companies, from global clinical research and development, through manufacturing, U.S. commercial compliance, and government programs. CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a “Culture of Compliance” that is both meaningful and sustainable.
For more information, visit www.cis-partners.com
